Prostate cancer is the most common malignancy in men. The 5-year relative survival for all stages combined is 98.8%. Patients diagnosed with metastatic prostate cancer have median survival from 2 to 3 years. We describe a case of 64-year old man who clinically presented with inguinal lymphadenopathy. Because of elevated PSA levels biopsy of prostate was done and adenocarcinoma was diagnosed. Biopsy of inguinal lymph nodes confirmed the diagnosis of prostate cancer. Hormonal treatment was started and at the most recent follow-up, 10 years later, the patient is asymptomatic with no clinical signs of disseminated disease
Context: The appropriate therapy for men with clinically localized prostate cancer is uncertain. A r...
A 79-year-old man underwent a transrectal prostate needle biopsy with a prostate-specific antigen (P...
Background: Little information is available on the long-term outcomes of patients with localised pro...
Prostate cancer is the most common malignancy in men. The 5-year relative survival for all stages co...
This study was undertaken to reveal the trends of prostate cancer and the outcome of treatment modal...
The most common method of spreading of prostate cancer is via direct invasion to the pelvic organs o...
Prostate cancer is predominantly a disease of older men. Patients generally present with urinary sym...
Prostatic adenocarcinoma is the most common cancer in men, and is the 3rd leading cause of death in ...
Objective To analyze patients from an underserved area who presented initially with metastatic pros...
AbstractProstate cancer typically metastasizes to bones and regional lymph nodes. Generalized lympha...
Introduction: Prostatic carcinoma has variable course of disease progression. Patients with metasta...
Prostatic carcinoma initially manifesting as only cervical lymph node swelling is a rare phenomenon....
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
A 60-year-old man visited the previous hospital with difficulty of urination in July 2004. Serum pro...
A 42-year-old man visited a community hospital with chief complaints of lumbago and dyschesia. Compu...
Context: The appropriate therapy for men with clinically localized prostate cancer is uncertain. A r...
A 79-year-old man underwent a transrectal prostate needle biopsy with a prostate-specific antigen (P...
Background: Little information is available on the long-term outcomes of patients with localised pro...
Prostate cancer is the most common malignancy in men. The 5-year relative survival for all stages co...
This study was undertaken to reveal the trends of prostate cancer and the outcome of treatment modal...
The most common method of spreading of prostate cancer is via direct invasion to the pelvic organs o...
Prostate cancer is predominantly a disease of older men. Patients generally present with urinary sym...
Prostatic adenocarcinoma is the most common cancer in men, and is the 3rd leading cause of death in ...
Objective To analyze patients from an underserved area who presented initially with metastatic pros...
AbstractProstate cancer typically metastasizes to bones and regional lymph nodes. Generalized lympha...
Introduction: Prostatic carcinoma has variable course of disease progression. Patients with metasta...
Prostatic carcinoma initially manifesting as only cervical lymph node swelling is a rare phenomenon....
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
A 60-year-old man visited the previous hospital with difficulty of urination in July 2004. Serum pro...
A 42-year-old man visited a community hospital with chief complaints of lumbago and dyschesia. Compu...
Context: The appropriate therapy for men with clinically localized prostate cancer is uncertain. A r...
A 79-year-old man underwent a transrectal prostate needle biopsy with a prostate-specific antigen (P...
Background: Little information is available on the long-term outcomes of patients with localised pro...